Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients — Stella

Home/Urinary Tract Infection, Recurrent/Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients

View on ClinicalTrials.gov

Recruiting

Back to Urinary Tract Infection, Recurrent trials

Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

University of California, San Diego, La Jolla, California

Key details

Phase

Early testing / Safety & dosing

Sponsor

University of California, San Diego

Collaborators

National Institutes of Health (NIH)

Enrollment target

~32 participants

Started

June 2025

Primary completion

October 2026

Age range

18 Years and older

Sex

Female only

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.